Background: The 6-min walk test (6MWT) is a common means of functional assessment. Its relationship to disability-free survival (DFS) is uncertain. Methods: This sub-study of the Measurement of Exercise Tolerance for Surgery study had co-primary outcome measures: correlation of the preoperative 6MWT distance with 30 day quality of recovery (15-item quality of recovery) and 12 month WHO Disability Assessment Schedule scores. The prognostic utility of the 6MWT and other risk assessment tools for 12 month DFS was assessed with logistic regression and receiver-operating-characteristic-curve analysis. Results: Of 574 patients recruited, 567 (99%) completed the 6MWT. Twelve months after surgery, 16 (2.9%) patients had died and 444 (77%) had DFS. The 6MWT correlated weakly with 30 day 15-item quality of recovery (r¼0.14; P¼0.001) and 12 month WHO Disability Assessment Schedule (r¼e0.23; P<0.0005) scores. When the cohort was split into 6MWT distance tertiles, the adjusted odds ratio of low vs high tertiles for DFS was 3.13 [95% confidence interval (CI): 1.54e6.35]. The only independent variable predictive of DFS was the Duke Activity Status Index (DASI) score (adjusted odds ratio: 1.06; P<0.0005). The area under the receiver-operating-characteristic curve for DFS was 0.63 (95% CI: 0.57e0.70) for the 6MWT, 0.60 (95% CI: 0.53e0.67) for cardiopulmonary-exercise-testing-derived peak oxygen consumption, and 0.70 (95% CI: 0.64e0.76) for the DASI score. Conclusions: Of the risk assessment tools analysed, the DASI was the most predictive of DFS. The 6MWT was safe and comparable with cardiopulmonary exercise testing for all predictive assessments. Future research should aim to determine the optimal 6MWT distance thresholds for risk prediction.
The Measurement of Exercise Tolerance for Surgery (METS) study compared three measures of functional capacity [subjective physician assessment, cardiopulmonary exercise testing (CPET), and the Duke Activity Status Index (DASI) score and plasma N-terminal pro-B-type natriuretic peptide (NTproBNP) concentrations] for their abilities to predict cardiovascular risk and mortality after non-cardiac surgery.
1 Whilst international practice guidelines 2, 3 recommend determining functional capacity (ability to exercise to more than four metabolic equivalents) for cardiovascular risk prediction, they do not identify a specific risk prediction tool or consider patient-centred outcomes other than mortality. The 6-min walk test (6MWT) is a simple, cheap, and clinically acceptable measure of functional capacity 4 that has been
shown to correlate well with CPET variables in patients with cardiopulmonary disease 5, 6 or undergoing major non-cardiac surgery. 7, 8 Evidence regarding the ability of the 6MWT to predict patient outcomes in the perioperative setting is limited to cohort studies with sample sizes of approximately 100 patients. In patients having thoracic or major general surgery, the 6MWT distance was predictive of postoperative complications 7, 9, 10 and hospital length of stay 10, 11 in some but not all studies, 12 and was predictive of mortality in patients undergoing bilateral lung volume reduction surgery for severe chronic airways disease. 11 Its ability to predict cardiovascular or patientcentred outcomes in a large surgical cohort is not known. Recent literature has highlighted the importance of using patient-centred outcome measures rather than surrogate measures to determine the success of surgery from the patient's perspective. 13e15 Two such measures that have been extensively validated in surgical patients include patient recovery as measured by the 15-item quality of recovery (QoR-15) score 16 and disability-free survival (DFS) as measured by the WHO Disability Assessment Schedule (WHODAS). 17 We therefore conducted a planned sub-study of METS with the aim of determining whether the 6MWT distance was associated with patient recovery and disability after surgery. The secondary aims of the sub-study were to confirm the correlation between preoperative CPET and the 6MWT, and to compare the predictive ability of the 6MWT to that of CPET, DASI, and NT-proBNP for DFS and the METS study outcomes of 30 day death and myocardial infarction and 12 month mortality after surgery.
Methods

Study design
This international prospective cohort study was conducted in Canada, Australia, and New Zealand as a sub-study of the METS study, the design methodology of which has previously been published. 1 Each study centre obtained research ethics board approval before commencing recruitment, and all participants provided written informed consent.
Participants and study procedures
Participants were eligible for inclusion if they were aged !40 yr, scheduled for elective non-cardiac surgery with a minimum of an overnight hospital stay, and had at least one cardiac risk factor. 1 The METS study protocol incorporated several preoperative assessments of cardiovascular risk, including CPET, subjective physician assessment, administration of the DASI survey, and plasma NT-proBNP concentration measurement. 1 In addition, participants in the substudy completed the 6MWT and 12-item WHODAS questionnaire before surgery, and the QoR-15 and WHODAS questionnaires 30 days and 12 months after surgery, respectively. The administration and scoring of the QoR-15 and the WHODAS have been described, 16, 17 with the WHODAS score ranging from a score of 0 (no disability) to 100% (complete disability). Clinically significant disability was defined as a WHODAS score of 25% or more, and a significant increase in disability was defined as an increase in WHODAS score of 8% or more from baseline. 17 New disability was defined as a significant increase in disability, with a final WHODAS score of at least 25%. DFS was defined as a patient who was both alive and free from clinically significant disability.
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Six-minute walk test
The 6MWT was conducted according to the American Thoracic Society guidelines. 4 Standardised instructions and encouragement were provided. The patients were asked to complete as many laps as possible in 6 min on a flat indoor 30 m course. Where possible, the patients completed the 6MWT on a different day to CPET. Where this was not possible, CPET was completed before the 6MWT, with an adequate break (at least 2 h) and refreshments provided between tests. To minimise bias, the investigators administering the 6MWT were blinded to the CPET results.
Study outcomes
The co-primary outcomes were the correlations between the preoperative 6MWT distance with quality of recovery 30 days after surgery and DFS 12 months after surgery. Secondary outcomes included the correlation between preoperative 6MWT distance and CPET-derived peak oxygen consumption (VO 2 peak), and a comparison of the predictive ability of the 6MWT and CPET for the sub-study primary outcomes, and the METS study primary (death or myocardial infarction within 30 days after surgery) and secondary (death within 1 yr after surgery) outcomes.
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Statistical analyses
The sample-size calculation was based on an expected correlation of 0.4 or greater between the 6MWT and each of the 30 day QoR-15 and 12 month WHODAS. A sample size of 480 patients was required to exclude a correlation of 0.3 (based on the lower 95% confidence limit) or greater, using a one-sided Type 1 error rate of 0.05 and a Type 2 error of 0.2, assuming linear, normal data. 19 To account for non-normal data and loss
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In a sub-study of the Measurement of Exercise Tolerance for Surgery study, the 6MWT was compared with other risk assessment tools as a predictor of postoperative outcome. The Duke Activity Status Index was the most predictive of disability-free survival, whilst the 6MWT was comparable with cardiopulmonary exercise testing.
to follow-up, we planned to enrol 550 patients. This sample size also provided adequate study power to allow separation of the cohort into 6MWT tertiles to enable an exploratory analysis and for receiver operating characteristic (ROC) analysis for the prediction of DFS. All patients who attempted the 6MWT and underwent surgery were included in the primary analysis. The associations between continuous variables were measured using Pearson correlation coefficients (r) or Spearman rank correlation (r). Proportions were compared using the c 2 test, parametric variables compared with independent sample t-test, and non-parametric variables compared with the independent sample ManneWhitney U-test. Based on the approach used in the METS study, 1 we first undertook univariate exploratory evaluations, followed by linear and logistic regression to model the significance of the extra prognostic information conveyed by the additional predictor variable. These models allowed the construction of ROC curves, both with and without the extra predictors. All analyses were done using SPSS for Windows V20.0 (SPSS Inc., Chicago, IL, USA).
Results
Participant characteristics
Fifteen hospitals across Australia, New Zealand, and Canada recruited 574 patients between July 2013 and November 2015 ( Fig. 1 ). Before surgery, all patients completed the 6MWT and 507 patients (88%) completed CPET. A total of 545 patients (95%) had surgery, and follow-up was complete in 544 patients (99.8%) at 30 days and 532 patients (97.6%) at 12 months. Patient characteristics were compared by 6MWT tertiles, where patients in the low 6MWT tertile walked less than 435 m, and patients in the high 6MWT tertile walked more than 510 m (Table 1) . Of note, patients in the low tertile were older (P<0.0005), less likely to be male (P<0.0005), had a higher ASA physical status score (P¼0.004), and were more likely to have arthritis with previous or scheduled joint replacement (P<0.0005). The majority of patients underwent intra-abdominal or pelvic procedures, with 199 patients (35%) having surgery for a malignancy and 84 patients (15%) being admitted to an intensive care or highdependency unit after surgery.
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Assessments of preoperative functional capacity
For the preoperative 6MWT, the mean distance walked was 473 (98) m ( Table 2 ). The test was terminated early in seven (1%) patients because of dizziness, lower limb pain, or shortness of breath (Supplementary Table S1 ), with the distance walked before termination recorded as the total 6MWT distance. No patient suffered an adverse event during the 6MWT. In contrast, of the 521 patients (91%) that attempted CPET, 71 (14%) terminated the test before completion. The VO 2 peak was measurable in 507 (97%) patients, with a mean of 20.7 (7.1) ml kg À1 min À1 . The adverse events and clinical sequelae relating to early termination of CPET are described elsewhere.
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Six-minute walk test distance
There was weak correlation between 6MWT distance and VO 2 peak (r¼0.36; P<0.0005) (Fig. 2) . However, patients in the low 6MWT tertile had a significantly lower VO 2 peak than those in the high 6MWT tertile (17.4 (5.8) vs 23.5 (6.8) ml kg À1 min À1 ; P<0.0005) ( Table 2 ). There was a moderate correlation between 6MWT distance and DASI score (r¼0.51; P<0.0005), and no significant correlation between 6MWT distance and NTproBNP (Table 3) .
Preoperative disability
Preoperative disability was present in 103 (18%) patients. There was a weak correlation between preoperative WHODAS scores and 6MWT distance (r¼e0.30; P<0.0005) ( Table 3) , but there was a higher proportion of patients with disability in the low compared with the high 6MWT tertile (30% vs 9%; P<0.0005) ( Table 2 ). There was a moderate correlation between preoperative WHODAS and DASI scores (r¼e0.53; P<0.0005) ( Table 3) ; when comparing the low and high 6MWT tertiles, DASI scores were significantly lower (32(13.8) vs 47(9.9); P<0.0005), and NT-proBNP levels were significantly higher [130.0 (52.5e322) vs 59.5 (29.5e124.8) pg ml À1 ; P<0.0005] in the low tertile group (Table 2) .
Postoperative outcomes
There was a weak correlation between preoperative 6MWT distance walked and the primary outcome measures of 30 day QoR-15 (r¼0.14; P¼0.001) and 12 month WHODAS (r¼e0.23; P<0.0005) ( Fig. 3 ; Table 3 ). There was no significant correlation between VO 2 peak and the 30 day QoR-15 score (P¼0.3), and weak correlation between VO 2 peak and the 12 month WHO-DAS score (r¼e0.23; P<0.00005) ( Table 3) . Most patients had recovered well by Day 30 after surgery with a median QoR-15 score of 133 (inter-quartile range: 118e141). Although statistically significant, there was no clinically important difference in recovery between the low and high 6MWT tertiles, with the difference in median QoR-15 scores (130 vs 135) being less than 8.0, the minimum clinically important difference for QoR-15 (Table 4) . 21 By 12 months after surgery, 72 patients (14%) had clinically significant disability, 47 (9%) had new disability, and 444 (77%) had DFS (Table 4) . Disability was significantly more common in the low 6MWT tertile, with the proportion of patients in the low vs high 6MWT tertiles being 22% vs 9% for disability, 13% vs 8% for new disability, and 74% vs 85% for DFS (P<0.0005 for all) ( Table 4) .
With regard to the METS study outcomes, 10 patients (1.7%) had died or experienced a myocardial infarction within 30 days of surgery, and 16 patients (2.9%) had died within 12 months of surgery. Both outcomes were significantly more common in the low 6MWT tertile group (Table 4) .
Predictive ability of preoperative testing
Logistic regression was used to determine which preoperative variables were most predictive of 12 month DFS. The METS outcome measures occurred too infrequently for regression modelling. The variables tested were patient age, ASA physical status score, 6MWT distance, VO 2 peak, DASI score, and NTproBNP.
Preliminary univariate testing was conducted using data from patients in the low and high 6MWT tertiles. The variables associated with DFS included age [odds ratio (OR): 1.05] and DASI (OR: 1.07). Forward stepwise regression in this restricted cohort revealed that DASI had an OR adjusted for age of 1.08 [confidence interval (CI): 1.05e1.10; P<0.0005]. DASI Table 2 Preoperative assessment characteristics by 6MWT distance tertile. Mean (standard deviation (SD)), median (inter-quartile range), and number (%). Data displayed are for lower (<435 m) and upper (>510 m) tertiles of 6MWT distances walked. EQ-5D, EuroQol-5D; METS, Measurement of Exercise Tolerance for Surgery; NT-ProBNP, N-terminal pro-B-type natriuretic peptide; VO 2 was then removed from the regression model to determine the impact of the tertile group on DFS. The OR, adjusted for age and ASA physical status, was 3.13 (95% CI: 1.54e6.35) depending on the tertile. When all patients and variables were included in a forward stepwise regression model, DASI was the only independent variable that predicted DFS, with an adjusted OR of 1.06 (CI: 1.04e1.08; P<0.0005). Similarly, NT pro-BNP was the only independent variable that predicted 12 month mortality, with an adjusted OR of 1.001 (CI: 1.000e1.002; P¼0.03). For DFS, the area under the ROC curve was 0.63 (95% CI: 0.57e0.70) for 6MWT distance, 0.60 (95% CI: 0.53e0.67) for VO 2 peak, 0.70 (95% CI: 0.64e0.76) for DASI score, and 0.56 (95% CI: 0.49e0.63) for NT-proBNP concentration (Table 5 ). For the METS study outcomes, 6MWT distance had an area under the ROC curve of 0.70 (95% CI: 0.52e0.88) for 30 day death or myocardial infarction, and 0.66 (95% CI: 0.52e0.80) for 12 month mortality, and for VO 2 peak was 0.5 for both outcomes (Table 5) .
On further exploratory analysis, 6MWT distance had relatively poor sensitivity (71%) and specificity (49%) for predicting DFS at the lower tertile cut point of 435 m. Using a lower 6MWT distance of 370 m improved sensitivity to 90% and specificity to 73%, with 75 patients (13%) from the cohort walking this distance or less. Of patients walking 370 m or less, 47% had significant preoperative disability, 29% had significant disability at 12 months, and 20% had a significant increase in disability (increase in WHODAS score of !8%).
Discussion
In this international prospective cohort study of non-cardiac surgery patients, the 6MWT was poorly predictive of recovery, DFS, or cardiovascular outcomes when used as a continuous scale. However, the 6MWT may have greatly improved the predictive ability when distance cut points are used to identify patients at risk. The CPET-derived VO 2 peak was even less predictive of DFS than the 6MWT, and was not predictive of the METS primary or secondary outcome measures.
A surprising finding of this study was the weak correlation between the 6MWT and CPET measurements, which has been reported as being between 0.64 and 0.75 in previous medical 6, 22, 23 and surgical studies. 8 Our findings may be more accurate, given the moderately sized and diverse surgical cohort, or may represent a problem with the standardised conduct of the 6MWT or CPET, or both across multiple international sites. The exploratory analysis revealed an improved predictive ability of the 6MWT when 6MWT distance was categorised by tertile. Patients walking more than 510 m were over three times more likely to have DFS at 12 months than those walking less than 435 m. Similarly, 30 day death or myocardial infarction, new disability, and mortality were all significantly more common in patients who walked less than 435 m. Sinclair and colleagues 8 also demonstrated that the 6MWT was most predictive of CPET variables using distance cut points rather than as a continuous scale in surgical patients. Further analysis of the ROC data demonstrated that the sensitivity and specificity of the 6MWT for predicting DFS were further improved at shorter walk distances, such as 370 m. Patients walking less than 370 m might be less likely to have DFS, because they have more preoperative disability and simply do not improve. However, preoperative WHODAS and 6MWT distance correlate poorly, suggesting that factors other than preoperative disability are involved. Further, patients walking less than 370 m had a 20% chance of a significant increase in disability, suggesting that the 6MWT reflects a change rather than perpetuation of the preoperative state. The notion that a lower 6MWT is a better threshold to delineate risk is consistent with previous research demonstrating increased mortality in thoracic surgery patients who walked less than 200 m before surgery.
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The DASI was the only independent variable predictive of 12 month DFS. For every point increase in the DASI score, there was a 6% increased chance of DFS. In contrast, unlike the entire METS study cohort, 18 the DASI was not predictive of myocardial infarction or mortality in this sub-study. NTproBNP had a modest predictive ability for the METS outcomes, but not DFS.
Overall, it is perhaps not surprising that the DASI and, to a lesser extent, the 6MWT test were most predictive of the patient-centred DFS outcome, as these tests measure constructs relating to overall patient function as opposed to just cardiovascular fitness or risk. Similarly, NT-proBNP and, to a lesser extent, the 6MWT were most predictive of 12 month mortality, reflecting the previous finding that elevated preoperative NT-proBNP is associated with an increased risk of death and non-fatal myocardial infarction more than 180 days after surgery. 24 Thus, the prediction of long-term disability and mortality a year after surgery may be most simply, cheaply, and accurately achieved by using the DASI, 6MWT, and NT-proBNP.
Limitations
One possible reason the 6MWT had only modest predictive ability for DFS at 1 yr may relate to the patient population and the timing of testing. For example, patients undergoing major joint arthroplasty who were unable to exercise before operation may have recovered to excellent function by the time they completed the WHODAS scale at 1 yr. This optimistic view may not reflect the experience of a sizeable proportion of such patients. In a previous cohort of 500 patients, orthopaedic patients had the poorest rate of DFS 6 months after surgery (67%), with the 18 major joint arthroplasty patients faring the worst (53% DFS). 17 This may be because patients have persistent pain causing ongoing functional limitation after surgery. Alternatively, it may be because patients who cannot exercise become unfit and deconditioned, and are therefore more susceptible to poor postoperative outcomes. Indeed, the inability to perform CPET is as predictive of poor postoperative outcome as a poor test result, suggesting that it is the inability to exercise rather than the reason for this inability (cardiovascular vs orthopaedic) that is predictive. 25 Several studies have demonstrated a learning effect with repeat 6MWT testing, with successively higher 6MWT distances achieved on repeat testing. 26 We chose not to conduct repeat 6MWT testing in this study, as the American Thoracic Society recommends that this is not necessary in all settings, 4 and previous research has demonstrated that the 6MWT is highly reproducible in surgical patients. 8 Further, whilst a consistent underestimate of 6MWT distance may affect the ability to determine the distance at which patients become at risk for complications, it should not affect the correlation between 6MWT and CPET or postoperative outcome variables. Whilst this is unlikely to affect the reliability of a test as simple as the 6MWT, it is recognised that CPET requires a specialised Therefore, it is conceivable that CPET results were affected by measurement bias, which could affect the correlation between VO 2 peak and other variables.
Future directions
Our findings support the notion that the optimal test for preoperative risk stratification will depend on the postoperative outcome one is trying to predict. For patient-centred outcomes, such as disability, this study suggests that functional patient-rated assessments, such as the DASI, are superior to exercise-based or laboratory testing, such as CPET. In contrast, biomarkers (such as NT-pro-BNP) may be more predictive for medium-term cardiovascular and mortality outcomes. Our findings suggest that the 6MWT is at least as predictive, for both patient-centred and traditional patient outcomes, as more expensive and labour-intensive CPET. The 6MWT may still have a role in functional and cardiovascular risk prediction, but the optimal threshold distance to define a high-risk patient (in our study, less than 370 m) still needs to be confirmed with further research.
Conclusions
The DASI questionnaire had the strongest, albeit modest, ability to predict DFS in intermediate-to high-risk non-cardiac surgical patients. Whilst preoperative 6MWT distance walked correlated weakly with 30 day recovery, 12 month DFS, and METS cardiovascular outcomes, it was comparable or superior to formal CPET for all outcomes measured. Clinicians should consider incorporating the DASI questionnaire, NT-proBNP measurement, and possibly the 6MWT into future perioperative risk assessment algorithms, especially when interested in patient-centred outcome.
